4060 MilliporeInosine - CAS 58-63-9 - Calbiochem
A metabolite of adenosine that acts as a potent coronary vasodilator. Exhibits a positive inotropic action on heart muscle and can antagonize the ouabain-induced arrhythmias.
More>> A metabolite of adenosine that acts as a potent coronary vasodilator. Exhibits a positive inotropic action on heart muscle and can antagonize the ouabain-induced arrhythmias. Less<<Inosine - CAS 58-63-9 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: Hypoxanthine Riboside
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 58-63-9 | C₁₀H₁₂N₄O₅ |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 4060-50GMCN | 塑胶安瓿;塑胶针药瓶 | 50 gm |
| References | |
|---|---|
| References | Aviado, D.M. 1983. J. Pharmacol. 14 (suppl. 3), 47. |
| Product Information | |
|---|---|
| CAS number | 58-63-9 |
| Form | White solid |
| Hill Formula | C₁₀H₁₂N₄O₅ |
| Chemical formula | C₁₀H₁₂N₄O₅ |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥99% by assay |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | NM7460000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Storage and Shipping Information | |
|---|---|
| Ship Code | Ambient Temperature Only |
| Toxicity | Standard Handling |
| Storage | +15°C to +30°C |
| Do not freeze | Ok to freeze |
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 4060-50GMCN | 04055977188523 |
Documentation
Inosine - CAS 58-63-9 - Calbiochem MSDS
| 职位 |
|---|
Inosine - CAS 58-63-9 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 4060 |
参考
| 参考信息概述 |
|---|
| Aviado, D.M. 1983. J. Pharmacol. 14 (suppl. 3), 47. |